Thumb Arthritis Market is experiencing significant expansion, driven by global demographic shifts and innovations in orthopedic care.

Thumb arthritis, primarily affecting the carpometacarpal (CMC) joint at the base of the thumb, causes pain, stiffness, and loss of function, severely impacting daily life. Valued at USD 0.47 Billion in 2024, the market is anticipated to soar to USD 1.15 Billion by 2035, exhibiting a robust Compound Annual Growth Rate (CAGR) of 8.48% from 2025 to 2035. This growth trajectory underscores the escalating demand for effective diagnosis and management solutions for this common yet debilitating condition.

The primary catalyst for this robust growth is the Rising Geriatric Population worldwide. As individuals age, the cumulative wear and tear on joints, especially the highly mobile and stressed CMC joint, significantly increases the likelihood of developing osteoarthritis. The vast demographic wave of people aged over 40—the demographic most commonly affected—is placing substantial strain on healthcare systems, driving demand for both symptomatic relief and definitive treatments, thereby fueling market revenues across all segments.